So what's the impact?
The fund's Morningstar OBSR Analyst Rating™ has now been placed 'under review'. The fund previously held a Bronze rating. Morningstar OBSR commented that Gemma Game had been the key driver of the fund’s success in recent years and they view her departure as a loss to the fund. In the interim period prior to her replacement, Mark Hargraves, Head of Continental Europe, will assume responsibility for the fund, and will be assisted by biotechnology fund manager Linden Thomson.
Morningstar OBSR will review the fund in due course once a permanent replacement has been appointed.
As always, if you have any questions feel free to contact the Willis Owen Customer Service team on 0800 597 2525.
We would love to hear what you think of our Insight area or if you have any questions or suggestions.Tell us what you think
Use our Fund and Equity research tool to find investment instruments that meet your criteria.Take me exploring
Why not take a look at : play which enables you to have a risk-free try at selecting funds?Find out about : play
Use our review tool to keep a track of the assets that you hold with the Willis Owen agency or elsewhere.Review my existing assets